A2RL
28.4.2024 13:58:27 CEST | Business Wire | Press release
TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire)
Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000 spectators at the circuit and captured the attention of over 600,000 online viewers in just 12 hours. Organized by ASPIRE, a subsidiary of Abu Dhabi’s Advanced Technology Research Council (ATRC), A2RL fuses extreme autonomous racing and AI to accelerate the global development of autonomous systems and technologies.
Following months of meticulous preparation spent refining driving AI algorithms in simulations, A2RL’s customized Dallara Super Formula SF23 cars tested the limits of human ingenuity and AI capability. Each team utilized an identical Super Formula race car - the fastest open-wheel race car in the world after Formula One- adapted for autonomous racing by the Technology Innovation Institute (TII), a sister company of ASPIRE.
Teams faced a complex task in coding. From understanding grip levels, managing tire temperatures, predicting opponent movements, performing successful overtakes, and operating the SF23 right at the limit of grip, the AI needed to perform all the things that racing drivers do intuitively. Additionally, with four autonomous cars racing on the track simultaneously, it marked a world-first attempt that added another layer of challenge.
In a last-lap shootout, the German outfit TUM snatched first place in a daring overtake when front-running Italian team UNIMORE slowed down and came to a stop on the track. The team was congratulated on the racetrack by H.H. Theyab bin Mohamed bin Zayed, who presented the Championship Trophy, along with H.E. Faisal Al Bannai, Secretary General, ATRC, and Strategic Research & Advanced Technology Affairs Advisor to the UAE President.
Simon Hoffmann, Team Principal, said: “This event has been nothing short of extraordinary, and the finale was our defining moment. We are absolutely thrilled with the outcome; it speaks volumes about our collective engineering prowess, coding expertise, and sheer determination. It's a testament to the incredible power of AI driving the evolution of autonomous mobility into the future!"
Spectators also enjoyed the riveting AI versus Human Race, where the Technology Innovation Institute (TII), pitted its autonomous car against renowned Formula One driver Daniil Kvyat. While Kvyat managed to hold his own and edge past his autonomous adversary by 10.38 secs, the spectacular 45-minute race highlighted just how close the autonomous race car performs against a human driver.
H.E. Al Bannai, said: “Through the Abu Dhabi Autonomous Racing League, we've sparked a race revolution. Showcasing fully autonomous racecars competing wheel-to-wheel, we've redefined the UAE's role in innovation and set a bold precedent for global mobility. This event isn't just a race; it's a transformative moment where technology, imagination, and ambition converge. A2RL serves as a beacon, inspiring the next generation through physical and virtual realities, while shaping a future where the impossible becomes achievable."
H.E. Dr. Sultan Al Jaber, Minister of Industry and Advanced Technology, and Group MD & CEO of ADNOC, as Title Sponsor, said: “Advances in artificial intelligence promise to transform every industry. The A2RL demonstrates the application of AI and as title sponsor, ADNOC is proud to help push the frontiers of science and innovation.”
Stephane Timpano, CEO of ASPIRE, said: “The launch of A2RL has reshaped the landscape of sports and technology, leaving a lasting impact for years to come. Moving forward, we're broadening our focus to include different vehicle types, while actively attracting top talent worldwide to showcase their mettle.”
On the sidelines of the main event, the A2RL STEM Challenge for high-school and undergrad students between the ages of 14 and 21 drew the participation of 18 local schools, in addition to an international entry from the Boys and Girls Club from Southeastern Michigan, to showcase their knowledge, skills, and innovation by racing 1:8 scale autonomous cars. The winner of the A2RL STEM Challenge was Heriot-Watt University.
A2RL pioneered the integration of mixed and virtual reality elements for the first time in autonomous racing. It gave each of the eight finalist teams a unique avatar persona and incorporated state-of-the-art Virtual Reality (VR) technology ahead of F1 implementation, igniting enthusiastic fan experience both online and offline. Fans at the event in Yas Marina Circuit got to enjoy insightful STEM workshops, intriguing VR challenges, Gran Turismo simulators, doodle cars, and a Raceum AI Museum, among other activities. The inaugural event concluded with a spectacular display of fireworks and drones, illuminating the iconic Yas Marina Circuit.
A2RL 2024 was successfully supported by ADNOC as Title Sponsor, and leading partners, including Du, DMT, AWS, and Mubadala, who played pivotal roles in shaping the event’s trajectory.
Details of the eight participating teams and other updates can be found at A2RL.io.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240428292385/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom